Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Atn-224
2. Tetrathiomolybdate
3. Tetrathiomolybdate Bis-choline Salt
4. Tetrathiomolybdate, Dipotassium Salt
5. Tetrathiomolybdate, Disodium Salt
6. Thiomolybdate
7. Ttm Cpd
1. 15060-55-6
2. Tiomolibdate Diammonium
3. Ammonium Tetrathiomolybdate(vi)
4. Molybdate(2-), Tetrathioxo-, Diammonium, (t-4)-
5. Ammonium Thiomolybdate
6. Ammonium Molybdenum Sulfide
7. Coprexa
8. Tiomolibdate Diammonium [usan]
9. Mfcd00136013
10. Attm
11. Att-m
12. 4v6i63lw1e
13. Diammonium Tetrathiomolybdate
14. Nsc-286644
15. Nsc-714598
16. Ammonium Tetrathiomolybdate [mi]
17. Ammonium Tetrathiomolybdate [who-dd]
18. Diazanium;bis(sulfanylidene)molybdenum;sulfanide
19. Ammonium Molybdenum Sulfide ((nh4)2mos4)
20. J-008719
21. Q4747310
22. Molybdate(2-), Tetrathioxo-, Ammonium (1:2), (t-4)-
23. Ammonium Tetrathiomolybdate(vi), 99% (99.99%-mo) Puratrem
Molecular Weight | 262.3 g/mol |
---|---|
Molecular Formula | H10MoN2S4 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | 263.878087 g/mol |
Monoisotopic Mass | 263.878087 g/mol |
Topological Polar Surface Area | 68.2 Ų |
Heavy Atom Count | 7 |
Formal Charge | 0 |
Complexity | 19.1 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 5 |
Angiogenesis Inhibitors
Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)
Chelating Agents
Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
ABOUT THIS PAGE
A Ammonium Tetrathiomolybdate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ammonium Tetrathiomolybdate, including repackagers and relabelers. The FDA regulates Ammonium Tetrathiomolybdate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ammonium Tetrathiomolybdate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ammonium Tetrathiomolybdate supplier is an individual or a company that provides Ammonium Tetrathiomolybdate active pharmaceutical ingredient (API) or Ammonium Tetrathiomolybdate finished formulations upon request. The Ammonium Tetrathiomolybdate suppliers may include Ammonium Tetrathiomolybdate API manufacturers, exporters, distributors and traders.
click here to find a list of Ammonium Tetrathiomolybdate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ammonium Tetrathiomolybdate DMF (Drug Master File) is a document detailing the whole manufacturing process of Ammonium Tetrathiomolybdate active pharmaceutical ingredient (API) in detail. Different forms of Ammonium Tetrathiomolybdate DMFs exist exist since differing nations have different regulations, such as Ammonium Tetrathiomolybdate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ammonium Tetrathiomolybdate DMF submitted to regulatory agencies in the US is known as a USDMF. Ammonium Tetrathiomolybdate USDMF includes data on Ammonium Tetrathiomolybdate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ammonium Tetrathiomolybdate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ammonium Tetrathiomolybdate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ammonium Tetrathiomolybdate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ammonium Tetrathiomolybdate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ammonium Tetrathiomolybdate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ammonium Tetrathiomolybdate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ammonium Tetrathiomolybdate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ammonium Tetrathiomolybdate suppliers with NDC on PharmaCompass.
Ammonium Tetrathiomolybdate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ammonium Tetrathiomolybdate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ammonium Tetrathiomolybdate GMP manufacturer or Ammonium Tetrathiomolybdate GMP API supplier for your needs.
A Ammonium Tetrathiomolybdate CoA (Certificate of Analysis) is a formal document that attests to Ammonium Tetrathiomolybdate's compliance with Ammonium Tetrathiomolybdate specifications and serves as a tool for batch-level quality control.
Ammonium Tetrathiomolybdate CoA mostly includes findings from lab analyses of a specific batch. For each Ammonium Tetrathiomolybdate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ammonium Tetrathiomolybdate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ammonium Tetrathiomolybdate EP), Ammonium Tetrathiomolybdate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ammonium Tetrathiomolybdate USP).
LOOKING FOR A SUPPLIER?